Search Results for: stem cell biotech

End of line for StemCells Inc., pioneering & controversial stem cell biotech

February 1, 2021 / By / 10 Comments
stemcellsinc-logo

A sad, but not surprising day for the stem cell field as the biotech StemCells, Inc. announced that it is winding down its operations after terminating its spinal cord injury trial called the Pathway Study. The data generated so far did not justify continuing the trial. StemCells, Inc. (stock symbol STEM) has struggled financially for …

End of line for StemCells Inc., pioneering & controversial stem cell biotech Read More »

Tale of 7 stem cell biotech stock woes

February 1, 2021 / By / 11 Comments
Ocata

To get from point A of a stem cell discovery to point B of a patient actually receiving a treatment based on that discovery is a long and non-linear road, which requires biotech company research. Stem cell biotech companies including publicly traded companies are an integral part of the field making that journey. How those …

Tale of 7 stem cell biotech stock woes Read More »

Wall Street Weirdness Over Stem Cell Biotech Intellicell (SVFC)

February 1, 2021 / By / 12 Comments
Steven-Victor

What the heck is going on with Intellicell Biosystems, Inc. (SVFC, also SVFCE), a stem cell corporation run by Dr. Steven Victor? Why are some on Wall Street seeming so bullish on the company lately? What’s the real story and the facts? What is the key background on this company? Wall Street has been buying …

Wall Street Weirdness Over Stem Cell Biotech Intellicell (SVFC) Read More »

Stem cell biotech of the year 2012: Advanced Cell Technology (ACTC)

February 1, 2021 / By / 4 Comments

For the second year in a row (see awards 2011), Advanced Cell Technology (ACT; stock symbol ACTC) is my stem cell biotech of the year. Their trials for different forms of macular degeneration (here and here and here) are progressing well and as a stem cell scientist I really appreciate the fact they are publishing their …

Stem cell biotech of the year 2012: Advanced Cell Technology (ACTC) Read More »

Stem Cell Biotech Advanced Cell Technology (ACT) gets $35 million

February 1, 2021 / By / 4 Comments

Advanced Cell Technology (ACT; stock symbol ACTC) announced that it has secured $35 million in funding from investment company, Lincoln Park Capital. The press release quotes CEO Gary Rabin: “We are most pleased about this financing agreement, as it has a number of notable benefits for the company,” commented Gary Rabin, chairman and CEO of …

Stem Cell Biotech Advanced Cell Technology (ACT) gets $35 million Read More »

Update on stem cell biotechs: an ethical investment, but risky and requiring patience.

February 1, 2021 / By

When I was at the recent World Stem Cell Summit, I had the opportunity to meet a ton of people from all different walks of life including other scientists in academia, folks in the biotech/pharma industry, and many inspiring patient advocates. A number of people were curious about my view on how the stem cell-related …

Update on stem cell biotechs: an ethical investment, but risky and requiring patience. Read More »

The recipe for success for stem cell biotechs such as Geron, ACT, and ViaCyte: 3 key ingredients

February 1, 2021 / By / 5 Comments

What will we define as a success for any given stem cell biotech? In academia, even if we do pre-clinical, translational kind of biomedical sciences, we still do not often think about what it takes to succeed in industry. Even if we very much want our research to make a difference for patients, do we …

The recipe for success for stem cell biotechs such as Geron, ACT, and ViaCyte: 3 key ingredients Read More »

Stem cell biotech updates: Geron, ACT, Neuralstem, Pfizer

February 1, 2021 / By / 2 Comments

What’s going on these days with biotech companies working on stem cell-based products? Geron’s and Advanced Cell Technology (ACT)’s FDA-approved trials presumably continue. As expected, no news yet. It’s too soon. Two important questions regarding both these companies are (1) did they apply for CIRM funding and (2) if so, how did the review process …

Stem cell biotech updates: Geron, ACT, Neuralstem, Pfizer Read More »

Stem cell good news on biotechs & cool new organoid paper

February 1, 2021 / By / 3 Comments
Pham-et-al.-2018

There’s some recent stem cell good news out there including new papers and biotech developments. The stem cell and regenerative medicine field is really diverse and runs the gamut from really worrying stuff to very exciting, legit developments. In this post, I’m going to focus on the encouraging recent developments. What do I see as …

Stem cell good news on biotechs & cool new organoid paper Read More »